You have 9 free searches left this month | to do more
Showing 1 - 25 of
6,230 items
Trials Per Page
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Endogenous Retroviruses in Acute Myeloid Leukemia
Recruiting
  • Leukemia, Myeloid
  • Demonstration of T cell responses
  • Pierre-Bénite, France
    Hôpital Lyon Sud
2021-07-26
Jul 26, 2021
C
Safety and Efficacy of CD123-Targeted CAR-T Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Chongqing, Chongqing, China
    Chongqing University Cancer Hospital
2021-03-01
Mar 1, 2021
C
CD123-Targeted CAR-T Cell Therapy for Relapsed/Refractory Acute Myeloid Leukemia
Recruiting
  • Leukemia
  • +2 more
  • CD123 CAR-T cells
  • Kunming, Yunnan, China
    920th Hospital of Joint Logistics Support Force
2021-03-01
Mar 1, 2021
G
Myeloid Mutations Register in R/R CML
Recruiting
  • Chronic Myeloid Leukaemia Recurrent
  • Chronic Myeloid Leukemia, in Relapse
  • Myeloid mutations measurement
  • Huixquilucan, Estado De México, Mexico
    Grupo Cooperativo de Hemopatías Malignas
2021-10-04
Oct 4, 2021
N
Pharmacokinetics of Venetoclax in Patients With Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Taipei, Taiwan
    National Taiwan University Hospital
2021-10-27
Oct 27, 2021
M
Flotetuzumab Expanded Access Program
Available
  • Acute Myeloid Leukemia
  • +2 more
  • flotetuzumab
  • (no location specified)
2021-08-18
Aug 18, 2021
A
TIGIT in Patients With Chronic Myeloid Leukemia
Not yet recruiting
  • Chronic Myeloid Leukemia
  • flow cytometry test
  • (no location specified)
2021-03-25
Mar 25, 2021
U
A Patient-centered Communication Tool (UR-GOAL) for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their Oncologists
Recruiting
  • Acute Myeloid Leukemia
  • Behavioral: UR-GOAL communication tool
  • Rochester, New York
    University of Rochester Medical Center
2021-10-04
Oct 4, 2021
U
KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Aurora, Colorado
  • +1 more
2021-08-30
Aug 30, 2021
P
IA14 Induction in Young Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • Idarubicin and cytarabine induction
  • Beijing, Beijing, China
    Xinxin Cao
2021-06-07
Jun 7, 2021
R
Natural Killer-cell Therapy for Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia Refractory
  • Acute Myeloid Leukemia, Relapsed, Adult
  • Nijmegen, Netherlands
    Radboud University Medical Center
2021-11-10
Nov 10, 2021
M
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • (no location specified)
2021-08-31
Aug 31, 2021
M
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
Active, not recruiting
  • Acute Myeloid Leukemia
  • Sample Collection Blood
  • Stool Sample
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
2021-05-17
May 17, 2021
M
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
2021-11-03
Nov 3, 2021
P
Study of ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Not yet recruiting
  • Acute Myeloid Leukemia, Adult
  • ADI-PEG 20
  • Houston, Texas
    MD Anderson Cancer Center
2021-08-11
Aug 11, 2021
S
Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies
Recruiting
  • Myeloid Leukemia, Acute
  • +3 more
  • Saint Petersburg, Russian Federation
    RM Gorbacheva Research Institute
2021-06-21
Jun 21, 2021
P
TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid Leukemia
Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • TAA05 cell injection
  • Hefei, Anhui, China
    Anhui Provincial Hospital
2021-11-03
Nov 3, 2021
O
Phase 1 Study of SGI-110 in Patients With Acute Myeloid Leukemia - 2019
Completed
Has Results
  • Acute Myeloid Leukemia
  • Kyoto, Japan
  • +2 more
2021-02-12
Feb 12, 2021
U
Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose
Recruiting
  • Chronic Myeloid Leukemia, Chronic Phase
    • Jena, Germany
      University Hospital Jena
    2021-08-12
    Aug 12, 2021
    H
    Dose Escalation Study of Minnelide in Relapsed or Refractory Acute Myeloid Leukemia
    Recruiting
    • Acute Myeloid Leukemia
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    2021-08-11
    Aug 11, 2021
    N
    TAK-243 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Refractory Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
    Not yet recruiting
    • Myelodysplastic Syndrome
    • +4 more
    • UAE Inhibitor TAK-243
    • (no location specified)
    2021-11-10
    Nov 10, 2021
    M
    Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia
    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +6 more
    • Houston, Texas
      M D Anderson Cancer Center
    2021-10-27
    Oct 27, 2021
    B
    A Study of MRX2843 in Subjects With Relapsed/Refractory Acute Myeloid Leukemia
    Not yet recruiting
    • Acute Myeloid Leukemia Leukemia
    • Shanghai, Shanghai, China
      Junmin Li，Ph.D
    2021-06-23
    Jun 23, 2021
    C
    Prevention of Chemotherapy Induced Cardiotoxicity in Children With Bone Tumors and Acute Myeloid Leukemia
    Recruiting
    • Cardiotoxicity
    • +2 more
    • Cairo, Egypt
      Children's Cancer Hospital Egypt 57357 Cairo, Egypt
    2021-08-02
    Aug 2, 2021
    O
    A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients - 2013
    Completed
    Has Results
    • Acute Myeloid Leukemia
    • Tokyo, Japan
      National Cancer Center
    2021-02-15
    Feb 15, 2021